financetom
Business
financetom
/
Business
/
BayWa secures additional $558 mln in financing as it seeks restructuring funds
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BayWa secures additional $558 mln in financing as it seeks restructuring funds
Oct 3, 2024 12:18 AM

Sept 29 (Reuters) - German agricultural group BayWa

said on Sunday that it had secured an additional 500

million euros ($558.15 million) as part of an existing bridging

loan agreement to sustain its financing till year end as it

seeks funding for restructuring.

The board expects to obtain signatures of the main lending

banks in the upcoming days to extend the existing standstill

agreements until Dec 31 2024, the statement added.

Last week, BayWa concluded the first draft of its

restructuring plan, which could include cost cuts and asset

sales and said it would continue talks with creditors and

shareholders.

On Friday, it also incurred a non-cash impairment loss of

222.2 million euros in the first half of 2024, more than half of

which was attributable to its renewable energy unit.

The Munich-based trader of farming supplies and produce has

been grappling with rising borrowing costs. In July, it also

suspended its annual profit forecast citing the restructuring

plans.

($1 = 0.8958 euros)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Theratechnologies Acquires Canadian Rights to 2 RNA Medicines From Ionis Pharmaceuticals
Theratechnologies Acquires Canadian Rights to 2 RNA Medicines From Ionis Pharmaceuticals
Dec 4, 2024
08:03 AM EST, 12/04/2024 (MT Newswires) -- Theratechnologies ( THTX ) said Wednesday it acquired exclusive Canadian rights to two investigational RNA-targeted medicines from Ionis Pharmaceuticals ( IONS ) . The agreement includes olezarsen, which is being evaluated for familial chylomicronemia syndrome and severe hypertriglyceridemia, and donidalorsen, which is being studied for hereditary angioedema treatment. Theratechnologies ( THTX ) will...
Insight Partners sells $2 bln stake in data firm Veeam at $15 bln valuation
Insight Partners sells $2 bln stake in data firm Veeam at $15 bln valuation
Dec 4, 2024
Dec 4 (Reuters) - U.S. private equity firm Insight Partners has sold a $2 billion stake in cloud data company Veeam Software in a secondary sale valuing the Swiss firm at $15 billion, it said on Wednesday. Veeam, which provides back up critical information on remote servers, has tripled its valuation from January 2020, when it was acquired by Insight...
TransAlta Closes Acquisition of Heartland Generation for $542 Million
TransAlta Closes Acquisition of Heartland Generation for $542 Million
Dec 4, 2024
08:04 AM EST, 12/04/2024 (MT Newswires) -- TransAlta ( TAC ) traded 1.3% higher at last look in NYSE pre-market trading Wednesday as it said it completed the acquisition of Heartland Generation and Alberta Power (2000) from Energy Capital Partners for $542 million. The acquisition includes Heartland's entire business operations in Alberta and British Columbia. TransAlta ( TAC ) said...
Update: Market Chatter: Chinese Industry Groups Say US Chips Are 'No Longer Safe,' Call on Chinese Firms to Buy Local
Update: Market Chatter: Chinese Industry Groups Say US Chips Are 'No Longer Safe,' Call on Chinese Firms to Buy Local
Dec 4, 2024
08:02 AM EST, 12/04/2024 (MT Newswires) -- (Update with Intel's ( INTC ) response to a request for comment.) Four of China's top industry associations on Tuesday said Chinese companies should be wary of buying US chips as they are no longer safe, and should buy local instead, Reuters reported Tuesday. Intel ( INTC ) , Nvidia ( NVDA )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved